Your browser is out of date. The site may not function correctly. Please update your browser.
BioGrad Diagnostics was set up by owner and chief executive Dr Natalie Kenny in 2014. Based at Liverpool Science Park, the firm was set up to offer laboratory and clinical training to science students, graduate researchers and teachers from across the globe.
In 2019 it attracted elite scientists from 526 institutes in 21 countries. However, after the COVID-19 pandemic hit in early 2020, BioGrad pivoted towards COVID testing and has since seen significant growth with EBITDA (a measure of profitability) expected to exceed £10m this year.